A class action lawsuit by Australian and New Zealand victims of Thalidomide against the anti-morning sickness drug's distributor Diageo Scotland has been settled for 89 million Australian dollars (£49 million).
A suit against the drug's German manufacturer Grunenthal Group will be discontinued.
Mr Gordon says more than 100 Thalidomide victims in Australia and New Zealand will receive compensation.
The drug was given to pregnant women in the 1950s and 1960s as a treatment for morning sickness, but was pulled from the market in 1961 after it was linked to birth defects. It led to deformities in thousands of babies.